Skip to content
MedsAcross

Manufacturer

Zameer Pharmaceuticals

Products listed
16
Molecules
6
Therapy areas
5

Zameer Pharmaceuticals is a pharmaceutical manufacturer based in an unrecorded country. MedsAcross lists 16 of its products across 6 molecules, each with registers, packs and availability for export supply to licensed buyers.

Indian manufacturer
No
Also listed as
Zameer Pharmaceuticals LLC
US FDA labeler
YesSource: openFDA NDC directory

Source from this manufacturer

We supply Zameer Pharmaceuticals products through licensed channels, with the documents your regulator needs.

Psychiatry

9 presentations

Psychiatry overview
MedicineActive ingredientRegisterAvailability
Chlorpromazine 10 mg tabletOralGeneric nameChlorpromazineUS FDAAvailable on request
Chlorpromazine 100 mg tabletOralGeneric nameChlorpromazineUS FDAAvailable on request
Chlorpromazine 200 mg tabletOralGeneric nameChlorpromazineUS FDAAvailable on request
Chlorpromazine 25 mg tabletOralGeneric nameChlorpromazineUS FDAAvailable on request
Chlorpromazine 50 mg tabletOralGeneric nameChlorpromazineUS FDAAvailable on request
Fluphenazine 1 mg tabletOralGeneric nameFluphenazineUS FDAAvailable on request
Fluphenazine 10 mg tabletOralGeneric nameFluphenazineUS FDAAvailable on request
Fluphenazine 2.5 mg tabletOralGeneric nameFluphenazineUS FDAAvailable on request
Fluphenazine 5 mg tabletOralGeneric nameFluphenazineUS FDAAvailable on request

Neurology

3 presentations

Neurology overview
MedicineActive ingredientRegisterAvailability
Oxcarbazepine 150 mg tabletOralGeneric nameOxcarbazepineUS FDAAvailable on request
Oxcarbazepine 300 mg tabletOralGeneric nameOxcarbazepineUS FDAAvailable on request
Oxcarbazepine 600 mg tabletOralGeneric nameOxcarbazepineUS FDAAvailable on request

Cardiology

2 presentations

Cardiology overview
MedicineActive ingredientRegisterAvailability
Ranolazine 1000 mg extended-release tabletOralGeneric nameRanolazineUS FDAAvailable on request
Ranolazine 500 mg extended-release tabletOralGeneric nameRanolazineUS FDAAvailable on request

Rheumatology

1 presentation

Rheumatology overview
MedicineActive ingredientRegisterAvailability
Naproxen 500 mg delayed-release tabletOralGeneric nameNaproxenUS FDAAvailable on request

Nephrology and urology

1 presentation

Nephrology and urology overview
MedicineActive ingredientRegisterAvailability
Trospium 20 mg tabletOralGeneric nameTrospiumUS FDAAvailable on request

Molecules made

Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.

Source from Zameer Pharmaceuticals

Send a request for any of these products. We confirm the licensed source, documents and lead time.